446 related articles for article (PubMed ID: 19561158)
1. Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice.
Elewaut D; Matucci-Cerinic M
Rheumatology (Oxford); 2009 Sep; 48(9):1029-35. PubMed ID: 19561158
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
[TBL] [Abstract][Full Text] [Related]
3. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept.
Braun J; Baraliakos X; Listing J; Sieper J
Arthritis Rheum; 2005 Aug; 52(8):2447-51. PubMed ID: 16052578
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor inhibitors in ankylosing spondylitis.
Reed MR; Taylor AL
Intern Med J; 2008 Oct; 38(10):781-9. PubMed ID: 18422565
[TBL] [Abstract][Full Text] [Related]
5. Biological therapies in the spondyloarthritides--the current state.
Braun J; Sieper J
Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
[TBL] [Abstract][Full Text] [Related]
6. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications.
El Maghraoui A
Eur J Intern Med; 2011 Dec; 22(6):554-60. PubMed ID: 22075279
[TBL] [Abstract][Full Text] [Related]
7. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents.
Braun J; Baraliakos X; Listing J; Davis J; van der Heijde D; Haibel H; Rudwaleit M; Sieper J
Arthritis Rheum; 2007 May; 57(4):639-47. PubMed ID: 17471540
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF-alpha therapy in ankylosing spondylitis.
De Keyser F; Van den Bosch F; Mielants H
Cytokine; 2006 Mar; 33(5):294-8. PubMed ID: 16516484
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of ankylosing spondylitis and undifferentiated spondyloarthritis with TNF alpha-antagonists].
Brandt J; Sieper J; Braun J
Z Rheumatol; 2003 Jun; 62(3):218-27. PubMed ID: 12827397
[TBL] [Abstract][Full Text] [Related]
10. Treatment of ankylosing spondylitis.
Clegg DO
J Rheumatol Suppl; 2006 Sep; 78():24-31. PubMed ID: 17042057
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF therapies in the management of acute and chronic uveitis.
Hale S; Lightman S
Cytokine; 2006 Feb; 33(4):231-7. PubMed ID: 16542849
[TBL] [Abstract][Full Text] [Related]
12. [Ankylosing spondylitis--the current situation and new therapeutic options].
Zlnay D; Zlnay M; Rovenský J
Vnitr Lek; 2006; 52(7-8):730-5. PubMed ID: 16967616
[TBL] [Abstract][Full Text] [Related]
13. Therapy for ankylosing spondylitis: new treatment modalities.
Braun J; Breban M; Maksymowych WP
Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):631-51. PubMed ID: 12406431
[TBL] [Abstract][Full Text] [Related]
14. Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art.
Fabiani C; Vitale A; Lopalco G; Iannone F; Frediani B; Cantarini L
Clin Rheumatol; 2016 Nov; 35(11):2631-2638. PubMed ID: 27686662
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of anti-tumor necrosis factor therapy for extra-articular manifestations in patients with ankylosing spondylitis: a meta-analysis.
Wu D; Guo YY; Xu NN; Zhao S; Hou LX; Jiao T; Zhang N
BMC Musculoskelet Disord; 2015 Feb; 16(1):19. PubMed ID: 25888248
[TBL] [Abstract][Full Text] [Related]
16. The effect of extra-articular manifestations on tumor necrosis factor-α inhibitor treatment duration in patients with ankylosing spondylitis: nationwide data from the Korean College of Rheumatology BIOlogics (KOBIO) registry.
Kim Y; Park S; Kim HS
Clin Rheumatol; 2018 Dec; 37(12):3275-3284. PubMed ID: 30251059
[TBL] [Abstract][Full Text] [Related]
17. IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy.
Jacquet A; Francois H; Frangie C; Yahiaoui Y; Ferlicot S; Micelli C; Mariette X; Durrbach A
Nephrol Dial Transplant; 2009 Nov; 24(11):3540-2. PubMed ID: 19556300
[TBL] [Abstract][Full Text] [Related]
18. Comment on: Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance.
Kobelt G
Rheumatology (Oxford); 2008 Oct; 47(10):1589-90; author reply 1590; discussion 1590-1. PubMed ID: 18710898
[No Abstract] [Full Text] [Related]
19. The treatment of ankylosing spondylitis.
Scalapino KJ; Davis JC
Clin Exp Med; 2003 Feb; 2(4):159-65. PubMed ID: 12624705
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.
Theodossiadis PG; Markomichelakis NN; Sfikakis PP
Retina; 2007; 27(4):399-413. PubMed ID: 17420690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
